Efficacy and safety of surufatinib in the treatment of patients with neuroendocrine tumor: a real-world study in Chinese population DOI Creative Commons
Yuanyuan Liu, Xinyi Yang, Yan Wang

et al.

BMC Cancer, Journal Year: 2024, Volume and Issue: 24(1)

Published: Oct. 31, 2024

Neuroendocrine tumors (NETs) are rare neoplasms that originate from peptidergic neurons and neuroendocrine cells. Due to their increasing incidence, effective treatment strategies required. Surufatinib, a novel small-molecule inhibitor with antiangiogenic immunomodulatory effects, has shown promise in clinical trials for advanced NETs. However, the efficacy safety of surufatinib influenced by multiple factors, there is currently lack sufficient real-world studies explore these potential influencing factors.

Language: Английский

Prognostic value of neutrophil-lymphocyte ratio in gastroenteropancreatic neuroendocrine neoplasm: a systematic review and meta-analysis DOI Creative Commons
Yajie Wang, Bei Wen, Yuxin Zhang

et al.

PeerJ, Journal Year: 2025, Volume and Issue: 13, P. e19186 - e19186

Published: April 7, 2025

Purpose A high neutrophil-to-lymphocyte ratio (NLR) might be connected with an unfavorable tumor prognosis. We sought to conduct a meta-analysis of published studies exploring the prognostic value NLR in patients gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN). Methods have referred PRISMA 2020 for Abstracts checklist and registered our review at International Prospective Register Systematic Reviews (registration number CRD42020187679). The PubMed, Embase, Web Science databases were screened using words like ‘neutrophil lymphocyte ratio’, ‘neuroendocrine tumors’, others up July 2024. In study, we evaluated significance on overall survival (OS), recurrence-free (RFS), progression-free (PFS) GEP-NEN. Subgroup analysis conducted identify origins heterogeneity examine impact factor grouping. Results gathered 18 cohorts 2,995 cases. All included quality, Newcastle Ottawa Scale (NOS) scores ranging from 6 8. pooled revealed that higher related worse OS (hazard (HR): 4.59, 95% confidence interval (CI) [3.35–6.29], p < 0.00001) poor RFS (HR: 4.05, CI [2.78–5.90], race, sites, therapy showed good predictive significance, however, is not effective predicting time non-operative patients. Conclusion This predicted OS, RFS, PFS GEP-NEN can used as promising predictor.

Language: Английский

Citations

0

A CECT-Based Radiomics Nomogram Predicts the Overall Survival of Patients with Hepatocellular Carcinoma After Surgical Resection DOI Creative Commons
Peng Zhang, Yue Shi,

Maoting Zhou

et al.

Biomedicines, Journal Year: 2025, Volume and Issue: 13(5), P. 1237 - 1237

Published: May 19, 2025

Objective: The primary objective of this study was to develop and validate a predictive nomogram that integrates radiomic features derived from contrast-enhanced computed tomography (CECT) images with clinical variables predict overall survival (OS) in patients hepatocellular carcinoma (HCC) after surgical resection. Methods: This retrospective analyzed the preoperative enhanced CT data 202 HCC who underwent resection at Affiliated Hospital North Sichuan Medical College (Institution 1) June 2017 2021 Nanchong Central 2) 2020 2022. Among these patients, 162 Institution 1 were randomly divided into training cohort (112 patients) an internal validation (50 7:3 ratio, whereas 40 2 assigned as independent external cohort. Univariate multivariate Cox proportional hazards regression analyses performed identify risk factors associated OS Using 3D-Slicer software, tumor lesions manually delineated slice by on non-contrast-enhanced (NCE) CT, arterial phase (AP), portal venous (PVP) generate volumetric regions interest (VOIs). Radiomic subsequently extracted VOIs. LASSO analysis employed for dimensionality reduction feature selection, culminating construction signature (Radscore). models, including model, radiomic–clinical developed prediction. performance models assessed via concordance index (C-index) time–ROC curves. optimal model further visualized nomogram, its accuracy evaluated calibration curves decision curve (DCA). Finally, interpreted Shapley additive explanations (SHAP). Results: revealed BCLC stage, albumin–bilirubin (ALBI), NLR–PLR score predictors three exhibited highest performance, C-indices 0.789, 0.726, 0.764 training, cohorts, respectively. Furthermore, showed 1-year 3-year AUCs 0.837 0.845 cohort, 0.801 0.880 0.773 0.840 Calibration DCA demonstrated model’s excellent applicability. Conclusions: combining CECT provides accurate prediction is beneficial clinicians developing individualized treatment strategies HCC.

Language: Английский

Citations

0

Research progress on the influence of traditional Chinese medicine on tumor microenvironment therapy DOI Creative Commons
Kun Gao, Yang Cao,

Zixin Ning

et al.

IntechOpen eBooks, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 14, 2024

More and more attention has been paid to the tumor microenvironment. The occurrence, development, metastasis, drug resistance of are closely related At same time, application traditional Chinese medicine (TCM) in prevention treatment attracted due its regulatory effect on cells holistic view multitarget TCM make it very suitable for regulation This article will review current research status molecular mechanism microenvironment from three aspects: can reverse inhibitory phenotype immune cells, enhance response clinical application.

Language: Английский

Citations

0

Prognostic Value of Systemic Inflammatory Markers and Scoring Systems in Predicting Postoperative 30-Day Complications and Mortality in Colorectal Cancer Surgery: A Retrospective Cross-Sectional Analysis DOI Open Access
Caner Akgul, Nuray Çolapkulu, Abdullah Güneş

et al.

Annali Italiani di Chirurgia, Journal Year: 2024, Volume and Issue: 95(4), P. 636 - 647

Published: Aug. 20, 2024

Language: Английский

Citations

0

Efficacy and safety of surufatinib in the treatment of patients with neuroendocrine tumor: a real-world study in Chinese population DOI Creative Commons
Yuanyuan Liu, Xinyi Yang, Yan Wang

et al.

BMC Cancer, Journal Year: 2024, Volume and Issue: 24(1)

Published: Oct. 31, 2024

Neuroendocrine tumors (NETs) are rare neoplasms that originate from peptidergic neurons and neuroendocrine cells. Due to their increasing incidence, effective treatment strategies required. Surufatinib, a novel small-molecule inhibitor with antiangiogenic immunomodulatory effects, has shown promise in clinical trials for advanced NETs. However, the efficacy safety of surufatinib influenced by multiple factors, there is currently lack sufficient real-world studies explore these potential influencing factors.

Language: Английский

Citations

0